Aquestive Therapeutics Overview

  • Status
  • Public
  • Employees
  • 187
Employees
  • Stock Symbol
  • AQST
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $3.56
  • (As of Tuesday Closing)

Aquestive Therapeutics General Information

Description

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Contact Information

Formerly Known As
MonoSol Rx
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 30 Technology Drive
  • Warren, NJ 07059
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aquestive Therapeutics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.56 $3.48 $3.17 - $9.46 $127M 36.6M 792K -$1.57

Aquestive Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 196,984 228,609 231,462 139,958
Revenue 48,206 45,849 52,609 67,430
EBITDA (34,114) (39,450) (54,660) (50,981)
Net Income (53,925) (55,783) (66,246) (61,376)
Total Assets 61,923 62,884 78,479 86,851
Total Debt 41,478 40,478 60,338 47,203
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aquestive Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aquestive Therapeutics‘s full profile, request access.

Request a free trial

Aquestive Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiate
Drug Delivery
Warren, NJ
187 As of 2020
000.00
0000 0000-00-00
00000000 000.00

00000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000

0000 000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
000000000000000
Oxnard, CA
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aquestive Therapeutics Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland 000000 000000000000
0000 0000000000000 Formerly Angel backed Oxnard, CA 00 0000 000000000 - 0000
0000 000000000000 Formerly VC-backed Bridgewater, NJ 000 00000 00000000000 00000
00000 000000000000 Private Equity-Backed Atlanta, GA 000 000.00 0000000000
00000000 0000 0000 Corporation Noida, India 0000 00000 00000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

Aquestive Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Keith Kendall Chief Executive Officer & Board Member
Ernie Toth Chief Financial Officer & Senior Vice President
Daniel Barber Chief Operating Officer, Operations & Senior Vice President
Mark Schobel Chief Technology Officer
Kenneth Marshall Executive & Senior Vice President
You’re viewing 5 of 9 executive team members. Get the full list »

Aquestive Therapeutics Board Members (6)

Name Representing Role Since
00000 00000000 Self Board Member 000 0000
00000 0000 00 Self Board Member 000 0000
00000 0000000 Aquestive Therapeutics Chief Executive Officer & Board Member 000 0000
00000 000000000 00 Self Board Member 000 0000
00000 000000 Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Aquestive Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aquestive Therapeutics Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000000 29-May-2007 0000000000 00000 Other Commercial Products 000 00000
00000000 (0000000 29-May-2007 0000000000 Other Containers and Packaging
RespondTV 26-Jul-2000 Later Stage VC 000.00 Social Content
To view Aquestive Therapeutics’s complete investments history, request access »

Aquestive Therapeutics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 26-Jul-2000 00000 00000 00 000.00 Completed
  • 8 buyers
To view Aquestive Therapeutics’s complete exits history, request access »